// App-Quantinova.ai

: Biomarker evidence of neurodegeneration in chronic kidney disease, in a general population

Researchers

Presenter

  • Anna Dittrich

Principal Investigators

  • Nicholas J. Ashton

  • Henrik Zetterberg

  • Kaj Blennow

  • Anna Zettergren

  • Joel Simrén

  • Sara Shams

  • Alejandra Machado

  • Eric Westman

  • Michael Schöll

  • Ingmar Skoog

  • Silke Kern

Medical Centers

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • University CollegeLondon, UK

  • King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute

  • Karolinska Institutet,

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • Institute of Physiology and Neuroscience, University of Gothenburg

  • Neuropsychiatric Epidemiology Unit, Institute of Neuroscience and Physiology, Sahlgrenksa Academy at the University of Gothenburg, Moelndal, Sweden

  • Department of Psychiatry Cognition and Old Age Psychiatry, Sahlgrenska University Hospital

  • UCL Queen Square Institute of Neurology

  • Wallenberg Centre for Molecular and Translational Medicine; University of Gothenburg,

  • UK Dementia Research Institute

  • NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Chronic kidney disease

Biomarkers

  • Creatinine

  • Neurofilament-light chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved